Literature DB >> 34031875

COVID-19-associated multisystem inflammatory syndrome in adults with Kawasaki disease-like cutaneous manifestations.

M Razmi T1, T P Afra1, T P Mohammed2, P T M Ashik3, E Sukesh4.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 34031875      PMCID: PMC8239693          DOI: 10.1111/bjd.20425

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   11.113


× No keyword cloud information.
Dear Editor, A 40‐year‐old Indian women, with normal vital observations, was referred to us for suspected drug rash. The rash appeared within a day of fever associated with unilateral cervical lymphadenopathy. Examination revealed strawberry tongue (a) and brightly erythematous acral skin that later peeled off (b, c). Blood investigation revealed lymphopenia, eosinophilia, abnormal liver function, raised C‐reactive protein (224 mg L–1) and erythrocyte sedimentation rate (39 mm h–1). COVID‐19 IgM was positive with negative IgG and reverse‐transcription polymerase chain reaction. Radiological evaluations and echocardiograph were noncontributory. With oral steroids, she had an uneventful hospital stay. Our patient had features of Kawasaki disease along with evidence of recent COVID‐19 infection, hepatic dysfunction and raised inflammatory markers fulfilling the Centers for Disease Control and Prevention criteria for multisystem inflammatory syndrome in adults (MIS‐A). Cutaneous findings (morbilliform, maculopapular and erythroderma) along with Kawasaki disease‐like features in adults in this pandemic scenario should prompt dermatologists to suspect MIS‐A.

Author Contribution

Muhammed Razmi T: Conceptualization (lead); Data curation (equal); Investigation (equal); Supervision (equal); Validation (equal); Writing‐original draft (lead); Writing‐review & editing (lead). TP Afra: Data curation (equal); Resources (equal); Validation (equal); Writing‐review & editing (equal). T. P Mohammed: Conceptualization (equal); Data curation (equal); Formal analysis (equal); Investigation (equal); Resources (equal); Validation (equal); Visualization (equal); Writing‐review & editing (equal). P. T Muhamed Ashik: Conceptualization (equal); Data curation (equal); Investigation (equal); Validation (equal); Visualization (equal); Writing‐review & editing (equal). Edavalath Sukesh: Data curation (equal); Investigation (equal); Validation (equal); Writing‐review & editing (equal).
  2 in total

1.  Case Series of Multisystem Inflammatory Syndrome in Adults Associated with SARS-CoV-2 Infection - United Kingdom and United States, March-August 2020.

Authors:  Sapna Bamrah Morris; Noah G Schwartz; Pragna Patel; Lilian Abbo; Laura Beauchamps; Shuba Balan; Ellen H Lee; Rachel Paneth-Pollak; Anita Geevarughese; Maura K Lash; Marie S Dorsinville; Vennus Ballen; Daniel P Eiras; Christopher Newton-Cheh; Emer Smith; Sara Robinson; Patricia Stogsdill; Sarah Lim; Sharon E Fox; Gillian Richardson; Julie Hand; Nora T Oliver; Aaron Kofman; Bobbi Bryant; Zachary Ende; Deblina Datta; Ermias Belay; Shana Godfred-Cato
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-10-09       Impact factor: 17.586

Review 2.  Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management.

Authors:  Jayakanthan Kabeerdoss; Rakesh Kumar Pilania; Reena Karkhele; T Sathish Kumar; Debashish Danda; Surjit Singh
Journal:  Rheumatol Int       Date:  2020-11-21       Impact factor: 2.631

  2 in total
  3 in total

1.  Clinical Characteristics of Multisystem Inflammatory Syndrome in Adults: A Systematic Review.

Authors:  Pragna Patel; Jennifer DeCuir; Joseph Abrams; Angela P Campbell; Shana Godfred-Cato; Ermias D Belay
Journal:  JAMA Netw Open       Date:  2021-09-01

2.  Response to 'COVID-19-associated multisystem inflammatory syndrome in adults with Kawasaki disease-like cutaneous manifestations': reply from the authors.

Authors:  T P Afra; M M Siraj; M Razmi T
Journal:  Br J Dermatol       Date:  2021-09-28       Impact factor: 11.113

3.  Response to 'COVID-19-associated multisystem inflammatory syndrome in adults with Kawasaki disease-like cutaneous manifestations'.

Authors:  Y S Pathania
Journal:  Br J Dermatol       Date:  2021-07-22       Impact factor: 11.113

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.